| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/03/2005 | US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex |
| 03/03/2005 | US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides |
| 03/03/2005 | US20050049201 Detection and removal of lead using lead-binding proteins |
| 03/03/2005 | US20050049198 Contacting a cardiac ryanodine receptor (RyR2) with a fragment of a dihydropyridine receptor (DHPR) polypeptide; ischemic heart disease, congestive heart failure, cardiac hypertrophy (calcium overload), dysrhythmia, or heart attack, cardiomyopathy |
| 03/03/2005 | US20050049197 Induction of immune response against desired determinants |
| 03/03/2005 | US20050049194 Use of ephrins and related molecules to regulate cellular proliferation |
| 03/03/2005 | US20050049193 Leptin-related peptides |
| 03/03/2005 | US20050049192 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/03/2005 | US20050049190 Cation conducting gabaa receptors and their use |
| 03/03/2005 | US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders |
| 03/03/2005 | US20050049188 G protein couple receptor for identifying modulators for treatment of cancers, infection, respiratory, nervous system, eating and pain disorders |
| 03/03/2005 | US20050049185 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof |
| 03/03/2005 | US20050049183 Using tamm-Horsefall glycoprotein to treat asthma, allergies, chronic inflammatory bowel disorders, viral infection, multiple sclerosis and migraines |
| 03/03/2005 | US20050049180 VGF polypeptides and methods of treating VGF-related disorders |
| 03/03/2005 | US20050049177 Proteolysis-resistant peptide hormones; peptide or polypeptide analogs that are resistant to cleavage by proteinases; use as therapeutic agents and in diagnosis |
| 03/03/2005 | US20050049176 Treating a hypoproliferative cell disorder or disorder involving increased cell death in a patient by administering a therapeutically effective amount of an EphA2 antagonistic agent; treatment of Inflammatory Bowel Disease |
| 03/03/2005 | US20050048646 Method for inducing cytotoxic T lymphocyte |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048629 theTat peptide is self cell-penetrating, is of HIV Type-1 and is bound to N-terminal amino acid residue of human parathyroid hormone-derived peptide; high stability and superior skin absorption; superior lipolysis effects and improved durability |
| 03/03/2005 | US20050048627 Tissue inhibitors of metalloproteinases (TIMP) for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 03/03/2005 | US20050048626 BAFF variants and methods thereof |
| 03/03/2005 | US20050048625 Mammalian cytokines; related reagents and methods |
| 03/03/2005 | US20050048624 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 03/03/2005 | US20050048623 Cell cycle and proliferation proteins |
| 03/03/2005 | US20050048622 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 03/03/2005 | US20050048620 Polynucleotides encoding a novel human neuronal cell adhesion protein, BGS-28, and variants thereof |
| 03/03/2005 | US20050048618 Zsig33-like peptides and polynucleotides |
| 03/03/2005 | US20050048616 Expression vector comprising nucleotide sequences coding endothelial-monocyte activating polypeptide (EMAP) for use in treatment, prevention and diagnosis of cell proliferative disorders |
| 03/03/2005 | US20050048615 Adipocyte complement related protein zacrp11 |
| 03/03/2005 | US20050048614 Biosynthetic oncolytic molecules and uses therefor |
| 03/03/2005 | US20050048613 Expression vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of lung and or colon tumors; antitumor agents |
| 03/03/2005 | US20050048612 Human epidermal proteins HEP1-1 to HEP1-6 |
| 03/03/2005 | US20050048610 Human transport proteins |
| 03/03/2005 | US20050048609 Fluorescent protein for use as diagnostic indicator in transformed plant or fish cells; biosensors |
| 03/03/2005 | US20050048608 Mammalian host cells for enhanced expression of a recombinant protein; bioreactors and genetic engineering |
| 03/03/2005 | US20050048607 Using activin receptor like kinases (ALK) as tool in identifying modulators for disganosis, prevention and treatment of cancer, rheumatoid arthritis and glomerulonephritis |
| 03/03/2005 | US20050048606 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist |
| 03/03/2005 | US20050048605 Novel polypeptide dna thereof and use of the same |
| 03/03/2005 | US20050048603 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis |
| 03/03/2005 | US20050048602 Kidney repairing factor |
| 03/03/2005 | US20050048600 Method for producing a multifunctional enzyme |
| 03/03/2005 | US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy |
| 03/03/2005 | US20050048589 Immunoglobulins for use in detecting, characterizing, preventing and treating human lung cancer; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048588 Mimetic amino acid sequences for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy; genetic vaccines |
| 03/03/2005 | US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste |
| 03/03/2005 | US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof |
| 03/03/2005 | US20050048577 Methods of using cytokine receptor zalpha11 to detect its ligands |
| 03/03/2005 | US20050048576 Diagnosing/prognosing nut allergies; immunodiagnostics |
| 03/03/2005 | US20050048560 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 03/03/2005 | US20050048559 Compositions and methods relating to breast specific genes and proteins |
| 03/03/2005 | US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides |
| 03/03/2005 | US20050048552 Higher order structure and binding of peptide nucleic acids |
| 03/03/2005 | US20050048550 Ephrin-A2 lymphocyte receptor modulator for use in treatment and prevention of renal cell carcinoma; mimetics and antitumor agents |
| 03/03/2005 | US20050048538 Hypocretin receptor in regulation of sleep and treatment of sleep disorders |
| 03/03/2005 | US20050048537 Novel human lipocalin homologs and polynucleotides encoding the same |
| 03/03/2005 | US20050048534 Expression vector comprising nucleotide sequences coding colon specific polypeptide for use in diagnosis, prevention, imaging and treatment of cell proliferative disorders; immunotherapy and diagnostics |
| 03/03/2005 | US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay |
| 03/03/2005 | US20050048522 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 03/03/2005 | US20050048520 Nogo receptor homologs |
| 03/03/2005 | US20050048508 Trehalose receptor and method for detecting trehalose with the same |
| 03/03/2005 | US20050048507 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/03/2005 | US20050048504 Human SGII-related gene variants associated with cancers |
| 03/03/2005 | US20050048502 Human SACH-related gene variants associated with cancers |
| 03/03/2005 | US20050048490 Cell growth, differentiation and death polypeptide (CGDD) for use in diagnosis, prevention and treatment of cell proliferative, developmental, neurological, autoimmune, inflammatory and reproductive disorders |
| 03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
| 03/03/2005 | US20050048483 Novel secreted proteins and their uses |
| 03/03/2005 | US20050048482 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm |
| 03/03/2005 | US20050048478 Preparing agents which prevent and/or treat viral diseases; immunotherapy; mimetics |
| 03/03/2005 | US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 03/03/2005 | US20050048472 Active truncated form of the RNA polymerase of flavivirus |
| 03/03/2005 | US20050048471 Albumin derivatives with therapeutic functions |
| 03/03/2005 | US20050048469 Novel human parvovirus B19 receptor and uses thereof |
| 03/03/2005 | US20050048467 Method and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin |
| 03/03/2005 | US20050048466 Recombinant virus comprising virus proliferating essential gene (VPEG) for use in the treatment of cell proliferative disorders; cancer therapeutics |
| 03/03/2005 | US20050048133 Methods for treating ischemic disorders using carbon monoxide |
| 03/03/2005 | US20050048082 Immunogen carrier; genetic engineering fusion protein |
| 03/03/2005 | US20050048081 Immunogenic compositions comprising DAL/DAT double mutant, auxotrophic attenuated strains of listeria and their mehods of use |
| 03/03/2005 | US20050048079 Induction response in cells; joining to adenosine triphosphate binding domain; therapy for Aids; anticancer agents |
| 03/03/2005 | US20050048078 Protein polymer having unfold activity on higher-order structure of protein |
| 03/03/2005 | US20050048077 Compositions, test kits and methods for detecting helicobacter pylori |
| 03/03/2005 | US20050048075 Protein isolation |
| 03/03/2005 | US20050048073 Methods of determining west nile virus epitopes and method of using the same |
| 03/03/2005 | US20050048071 Short peptide associated with leukemia that induces immunology response; cancer vaccine; leukemia antigen |
| 03/03/2005 | US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines |
| 03/03/2005 | US20050048069 Methods and compositions for modulating immunity |
| 03/03/2005 | US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response |
| 03/03/2005 | US20050048067 Antiproliferative agents; therapy for autoimmune disease |
| 03/03/2005 | US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit |
| 03/03/2005 | US20050048064 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 03/03/2005 | US20050048062 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 03/03/2005 | US20050048058 Antibody against fibroblast growth factor-23 |
| 03/03/2005 | US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide |
| 03/03/2005 | US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells |
| 03/03/2005 | US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/03/2005 | US20050048030 Parainfluenza virus, respiratory syncytial virus infection genetic engineering vectors; heterologous nucleic acids |
| 03/03/2005 | US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections |
| 03/03/2005 | US20050048027 Non-neurotoxic plasminogen activating factors for treating stroke |
| 03/03/2005 | DE10336760A1 Method for in vivo labeling of defined cell types in a tissue, useful for detecting specific cells and to establish expression profiles, by providing cell-specific expression of fluorescent protein |
| 03/03/2005 | DE10333675A1 Perfusionsverfahren für die Produktion von Erythropoietin Perfusion for the production of erythropoietin |
| 03/03/2005 | DE10331879A1 Wirkstofftransportsystem Drug delivery system |